Pyrazole compounds useful as protein kinase inhibitors

Details for Australian Patent Application No. 2002245198 (hide)

Owner VERTEX PHARMACEUTICALS INCORPORATED

Inventors Bebbington, David; Kay, David; Charrier, Jean-Damien; Patel, Sanjay; Davies, Robert; Knegtel, Ronald; Golec, Julian

Agent Cullens

Pub. Number AU-A-2002245198

PCT Pub. Number WO2002/059111

Priority 60/286,949 27.04.01 US; 60/257,887 21.12.00 US

Filing date 19 December 2001

Wipo publication date 6 August 2002

International Classifications

C07D 403/12 Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

A61K 031/517 - ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine

A61P 035/00 Antineoplastic agents

Event Publications

6 February 2003 Application Open to Public Inspection

  Published as AU-A-2002245198

27 April 2006 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(e). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002245199

2002245197-Methods of producing substantially anatase-free titanium dioxide with silicon halide addition